Progress of the treatment for Pneumocystis jirovecii pneumonia in non-HIV immunocompromised patients
Jiang Hui
Zhang Qiu-bin
Zhu Hua-dong
Abstract：With the increasing use of immunosuppressive medications and chemotherapeutics, Pneumocystis jirovecii pneumonia (PJP) has become a prevalent opportunistic infection in the non-HIV population.In these patients, the incidence increased year by year and the mortality was high.In addition, Pneumocystis jirovecii appears resistant to prophylactic sulfonamides.In order to improve the prognosis of these patients, this review summarizes research progress on the treatment for PJP in non-HIV immunocompromised patients.
Keywords：Non-HIV patientPneumocystis jirovecii pneumonia (PJP)TreatmentTMP/SMXClindamycin-primaquineCaspofungin
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 770-773 )